American Regent intros epinephrine injection

American Regent is releasing 30 ml epinephrine injection.

Epinephrine injection is indicated for emergency treatment of allergic reactions (Type I), including anaphylaxis, which may result from insect stings or bites, foods, drugs, sera, diagnostic testing substances and other allergens, as well as idiopathic anaphylaxis or exercise-induced anaphylaxis. Epinephrine also is indicated to increase mean arterial blood pressure in adult patients with hypotension associated with septic shock.

[Read more: FDA approves first nasal spray for anaphylaxis]

"With the approval of epinephrine injection we continue to show our commitment to ensuring both patients and providers have access to high-quality treatment options," said Joann Gioia, vice president and chief commercial officer at American Regent.

[Read more: American Regent intros epinephrine injection]